# CAMBRIDGE EPIGENETIX Ltd — Form D

CAMBRIDGE EPIGENETIX Ltd of Cambridge, X0, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-09. The offering totals $12.3M, of which $12.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-05-09
- Form: D
- Accession: 0001104659-18-031584
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.3M
- Amount sold: $12.3M
- Investors: 15
- Date of first sale: 2018-04-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-311955

## Issuer

- Name: CAMBRIDGE EPIGENETIX Ltd
- CIK: 0001739567
- Entity type: Corporation
- Jurisdiction: UNITED KINGDOM
- Address: 30 Broad Street, Cambridge, X0, CB23 6HJ
- Phone: +44 1223 800700

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Shankar Balasubramanian | Director | Cambridge, X0 |
| Thomas Hulme | Director | Cambridge, X0 |
| Jason Mellad | Director | Cambridge, X0 |
| Martin Murphy | Director | Cambridge, X0 |
| Alice Newcombe-Ellis | Director | Cambridge, X0 |
| Timothy Rink | Director | Cambridge, X0 |
| Somasundaram Subramaniam | Director | San Diego, CA |
| Bobby Yerramilli-Rao | Director | Cambridge, X0 |
| Jason Mellad | Executive Officer | Cambridge, X0 |

## More

- [CIK 1739567 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1739567&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001104659-18-031584.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.